Search results

  1. Renal and ureteric stones

    Everything NICE has said on assessing and managing renal and ureteric stones in children, young people and adults in an interactive flowchart.

  2. Bipolar disorder

    Everything NICE has said on recognising, assessing and managing bipolar disorder in children, young people and adults in an interactive flowchart

  3. Preventing type 2 diabetes

    Everything NICE has said on preventing type 2 diabetes in an interactive flowchart

  4. Ear, nose and throat conditions

    Everything NICE has said on ear, nose and throat conditions in an interactive flowchart

  5. Blood transfusion

    Everything NICE has said on blood transfusions in adults, young people and children over 1 year old in an interactive flowchart

  6. Depression

    Everything NICE has said on identifying, treating and managing depression in children, young people and adults in an interactive flowchart

  7. Urinary tract infections

    Everything NICE has said on diagnosing, treating and managing urinary tract infections including lower (cystitis), upper (acute pyelonephritis) and recurrent UTIs in people with or without a catheter in an interactive flowchart

  8. Trauma

    Everything NICE has said on assessing and managing trauma in an interactive flowchart

  9. Suspected cancer recognition and referral

    Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart

  10. Hip fracture

    Everything NICE has said on managing hip fracture in adults in an interactive flowchart

  11. Chest pain

    Everything NICE has said on assessing and managing recent suspected cardiac chest pain including acute coronary syndromes and stable angina in an interactive flowchart

  12. Colorectal cancer

    Everything NICE has said on diagnosing and managing colorectal (bowel) cancer in an interactive flowchart

  13. Hypertension

    Everything NICE has said on managing hypertension in adults in an interactive flowchart

  14. Diabetes in children and young people

    Everything NICE has said on diagnosing and managing type 1 and 2 diabetes in children and young people in an interactive flowchart

  15. Type 1 diabetes in adults

    Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart

  16. Chronic kidney disease

    Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart

  17. Multiple sclerosis

    Everything NICE has said on multiple sclerosis in an interactive flowchart

  18. Safer insulin prescribing (KTT20)

    This document summarises the evidence base on safer insulin prescribing . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  19. Multimorbidity and polypharmacy (KTT18)

    This document summarises the evidence base on multimorbidity and polypharmacy . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  20. Anticoagulants, including direct-acting oral anticoagulants (DOACs) (KTT16)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on anticoagulants , including direct-acting oral anticoagulants (DOACs). It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  21. Biosimilar medicines (KTT15)

    The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  22. Wound care products (KTT14)

    This document summarises the evidence base on wound care products . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  23. Non-steroidal anti-inflammatory drugs (KTT13)

    The key therapeutic topic non-steroidal anti-inflammatory drugs has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  24. Antipsychotics in people living with dementia (KTT7)

    This document summarises the evidence base on antipsychotics in people living with dementia . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  25. Hypnotics (KTT6)

    This document summarises the evidence base on hypnotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  26. Asthma: medicines safety priorities (KTT5)

    This document summarises the evidence base on asthma: medicines safety priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  27. Lipid-modifying drugs (KTT3)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on lipid-modifying drugs. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  28. Shared decision making (KTT23)

    This document summarises the evidence base on shared decision making . It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance .

  29. Chemotherapy dose standardisation (KTT22)

    This document summarises the evidence base on chemotherapy dose standardisation . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  30. Type 2 diabetes mellitus: medicines optimisation priorities (KTT12)

    This document summarises the evidence base on type 2 diabetes mellitus: medicines optimisation priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .